This episode provides a detailed overview of Colombia's medical device risk classification system as regulated by INVIMA under Decree 4725 of 2005. We explain the four-tiered risk classes (Class I, IIa, IIb, and III), the criteria used for classification such as invasiveness and duration of use, and how a device's class determines its regulatory pathway for market approval in this key Latin American market.

- What is the primary regulation governing medical device classification in Colombia?

- How does INVIMA define Class I, IIa, IIb, and III medical devices?

- What are the key factors used to determine a device's risk classification?

- Why is correct classification the most critical first step for market entry in Colombia?

- How does a device's risk class impact the INVIMA registration process and timeline?

- Which international classification models is Colombia's system harmonized with?

- Can you provide examples of devices for each of the four risk classes?

- What is the difference in the regulatory pathway for low-risk versus high-risk devices?

Pure Global offers end-to-end consulting to streamline your entry into over 30 global markets, including Colombia. Our local experts and advanced AI tools simplify complex regulatory challenges. We manage your technical dossier preparation, act as your official in-country representative for INVIMA, and develop a clear regulatory strategy to ensure your device meets all requirements under Decree 4725. With Pure Global, a single registration process can open doors to multiple markets, accelerating your global expansion efficiently. Contact us at [email protected], visit https://pureglobal.com, or explore our free AI regulatory tools at https://pureglobal.ai.